These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 30786220)

  • 41. Kratom: Substance of Abuse or Therapeutic Plant?
    Gorelick DA
    Psychiatr Clin North Am; 2022 Sep; 45(3):415-430. PubMed ID: 36055730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research.
    Henningfield JE; Fant RV; Wang DW
    Psychopharmacology (Berl); 2018 Feb; 235(2):573-589. PubMed ID: 29273821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic.
    Garcia-Romeu A; Cox DJ; Smith KE; Dunn KE; Griffiths RR
    Drug Alcohol Depend; 2020 Mar; 208():107849. PubMed ID: 32029298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management.
    Bowe A; Kerr PL
    J Psychoactive Drugs; 2020; 52(5):447-452. PubMed ID: 32546067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiological trends in electronic cigarette exposures reported to U.S. Poison Centers.
    Vakkalanka JP; Hardison LS; Holstege CP
    Clin Toxicol (Phila); 2014 Jun; 52(5):542-8. PubMed ID: 24792781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patch Problems? Characteristics of Transdermal Drug Delivery System Exposures Reported to the National Poison Data System.
    Thornton SL; Darracq MA
    J Med Toxicol; 2020 Jan; 16(1):33-40. PubMed ID: 31410729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kratom (Mitragyna speciosa): Friend or Foe?
    Sethi R; Hoang N; Ravishankar DA; McCracken M; Manzardo AM
    Prim Care Companion CNS Disord; 2020 Jan; 22(1):. PubMed ID: 31999896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of Tianeptine Exposures Reported to the National Poison Data System - United States, 2000-2017.
    El Zahran T; Schier J; Glidden E; Kieszak S; Law R; Bottei E; Aaron C; King A; Chang A
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(30):815-818. PubMed ID: 30070980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prescription Opioid Exposures Among Children and Adolescents in the United States: 2000-2015.
    Allen JD; Casavant MJ; Spiller HA; Chounthirath T; Hodges NL; Smith GA
    Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28320869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trends in intentional abuse and misuse ingestions in school-aged children and adolescents reported to US poison centers from 2000-2020.
    Hughes AR; Grusing S; Lin A; Hendrickson RG; Sheridan DC; Marshall R; Horowitz BZ
    Clin Toxicol (Phila); 2023 Jan; 61(1):64-71. PubMed ID: 36469528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.
    Warner ML; Kaufman NC; Grundmann O
    Int J Legal Med; 2016 Jan; 130(1):127-38. PubMed ID: 26511390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of poison exposure data: NHIS and TESS data.
    Polivka BJ; Elliott MB; Wolowich WR
    J Toxicol Clin Toxicol; 2002; 40(7):839-45. PubMed ID: 12507052
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patterns of Kratom use and health impact in the US-Results from an online survey.
    Grundmann O
    Drug Alcohol Depend; 2017 Jul; 176():63-70. PubMed ID: 28521200
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kratom: A growing substance of abuse in the United States.
    Demick DS; Lee TT; Summers AT; El-Mallakh RS
    Ann Clin Psychiatry; 2020 Nov; 32(4):275-280. PubMed ID: 32722734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users.
    Singh D; Müller CP; Vicknasingam BK
    Drug Alcohol Depend; 2014 Jun; 139():132-7. PubMed ID: 24698080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kratom as a substitute for opioids: Results from an online survey.
    Coe MA; Pillitteri JL; Sembower MA; Gerlach KK; Henningfield JE
    Drug Alcohol Depend; 2019 Sep; 202():24-32. PubMed ID: 31284119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thirteen years of oxcarbazepine exposures reported to US poison centers: 2000 to 2012.
    Spiller HA; Strauch J; Essing-Spiller SJ; Burns G
    Hum Exp Toxicol; 2016 Oct; 35(10):1055-9. PubMed ID: 26612556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increasing frequency and fatality of poison control center reported exposures involving medication and multiple substances: data from reports of the American Association of Poison Control Centers 1984-2013.
    Greenwald PW; Farmer BM; O'Neill M; Essner RA; Flomenbaum NE
    Clin Toxicol (Phila); 2016 Aug; 54(7):590-6. PubMed ID: 27214065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Indicators for serious kidney complications associated with toxic exposures: an analysis of the National Poison Data System.
    Vilay AM; Wong CS; Schrader RM; Mercier RC; Seifert SA
    Clin Toxicol (Phila); 2013 Feb; 51(2):96-105. PubMed ID: 23331216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of cosmetic product exposures reported to the Milan Poison Control Centre, Italy from 2005 to 2010.
    Ruggiero S; Moro PA; Davanzo F; Capuano A; Rossi F; Sautebin L
    Clin Toxicol (Phila); 2012 Dec; 50(10):902-10. PubMed ID: 23134375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.